Hubbry Logo
DiuresisDiuresisMain
Open search
Diuresis
Community hub
Diuresis
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Diuresis
Diuresis
Diuresis
View on Wikipedia
from Wikipedia

Diuresis (/ˌdaɪjʊˈriːsɪs/) is the excretion of urine, especially when excessive (polyuria). The term collectively denotes the physiologic processes underpinning increased urine production by the kidneys during maintenance of fluid balance.[1]

In healthy people, the drinking of extra water produces mild diuresis to maintain the body water balance. Many people with health issues, such as heart failure and kidney failure, need diuretic medications to help their kidneys deal with the fluid overload of edema. These drugs promote water loss via urine production. The concentrations of electrolytes in the blood are closely linked to fluid balance, so any action or problem involving fluid intake or output (such as polydipsia, polyuria, diarrhea, heat exhaustion, starting or changing doses of diuretics, and others) can require management of electrolytes, whether through self-care in mild cases or with help from health professionals in moderate or severe cases.[citation needed]

Osmotic diuresis

[edit]

Osmotic diuresis is the increase of urination rate caused by the presence of certain substances in the proximal tubule (PCT) of the kidneys.[2] The excretion occurs when substances such as glucose enter the kidney tubules and cannot be reabsorbed (due to a pathological state or the normal nature of the substance). The substances cause an increase in the osmotic pressure within the tubule, causing retention of water within the lumen, and thus reduces the reabsorption of water, increasing urine output (i.e., diuresis). The same effect can be seen in therapeutics such as mannitol, which is used to increase urine output and decrease extracellular fluid volume.[citation needed]

Substances in the circulation can also increase the amount of circulating fluid by increasing the osmolarity of the blood. This has the effect of pulling water from the interstitial space, making more water available in the blood, and causing the kidney to compensate by removing it as urine. In hypotension, colloids are used often intravenously to increase circulating volume in themselves, but as they exert a certain amount of osmotic pressure, water is therefore also moved, further increasing circulating volume. As blood pressure increases, the kidney removes the excess fluid as urine. Sodium, chloride and potassium are excreted in osmotic diuresis, originating from diabetes mellitus (DM). Osmotic diuresis results in dehydration from polyuria and the classic polydipsia (excessive thirst) associated with DM.[3][4]

Forced diuresis

[edit]
"Forced diuresis", "Forced alkaline diuresis", and "Forced acid diuresis" redirect here.
Renal diuretics

Forced diuresis (increased urine formation by diuretics and fluid) may enhance the excretion of certain drugs in urine and is used to treat drug overdose or poisoning of these drugs and hemorrhagic cystitis.[5]

Diuretics

[edit]
Main article: Diuretic

Most diuretic drugs are either weak acids or weak bases. When urine is made alkaline, elimination of acidic drugs in the urine is increased. The converse applies for alkaline drugs. This method is only of therapeutic significance where the drug is excreted in active form in urine and where the pH of urine can be adjusted to levels above or below the pK value of the active form of drug. For acidic drugs, urine pH should be above the pK value of that drug, and converse for the basic drugs. It is because the ionization of acidic drug is increased in alkaline urine and ionized drugs cannot easily cross a plasma membrane so cannot re-enter blood from kidney tubules. This method is ineffective for drugs that are strongly protein bound (e.g., tricyclic antidepressants) or which have a large apparent volume of distribution (e.g. paracetamol, tricyclic antidepressants).[6]

For forced alkaline diuresis, sodium bicarbonate is added to the infusion fluid to make blood and, in turn, urine alkaline. Potassium replacement becomes of utmost importance in this setting because potassium is usually lost in urine. If blood levels of potassium are depleted below normal levels, then hypokalemia occurs, which promotes bicarbonate ion retention and prevents bicarbonate excretion, thus interfering with alkalinization of the urine. Forced alkaline diuresis has been used to increase the excretion of acidic drugs like salicylates and phenobarbitone, and is recommended for rhabdomyolysis.[medical citation needed]

For forced acid diuresis, ascorbic acid (vitamin C) is sometimes used. Ammonium chloride has also been used for forced acid diuresis, but it is a toxic compound.[7] Usually, however, this technique only produces a slight increase in the renal clearance of the drug. Forced acid diuresis is rarely done in practice,[citation needed] but can be used to enhance the elimination of cocaine, amphetamine, quinine, quinidine, atropine and strychnine when poisoning by these drugs has occurred.[citation needed]

Rebound diuresis

[edit]
An example of the pattern of urine flow and plasma creatinine levels following acute tubular necrosis

Rebound diuresis refers to the sudden resurgence of urine flow that occurs during recovery from acute kidney injury.[8] In acute kidney injury, particularly acute tubular necrosis, the tubules become blocked with cellular matter, particularly necrotic sloughing of dead cells. This debris obstructs the flow of filtrate, which results in reduced output of urine. The arterial supply of the nephron is linked to the filtration apparatus (glomerulus), and reduced perfusion leads to reduced blood flow; usually this is the result of pre-renal pathology.[9]

The kidney's resorptive mechanisms are particularly energetic, using nearly 100% of the O2 supplied. Thus, the kidney is particularly sensitive to reduction in blood supply. This phenomenon occurs because renal flow is restored prior to the normal resorption function of the renal tubule. As shown by the graph, urine flow recovers rapidly and subsequently overshoots the typical daily output (between 800 mL and 2L in most people). Since the kidney's resorption capacity takes longer to re-establish, there is a minor lag in function that follows recovery of flow. A good reference range for plasma creatinine is between 0.07 - 0.12 mmol/L.[10]

Immersion diuresis

[edit]

Immersion diuresis is caused by immersion of the body in water (or equivalent liquid). It is mainly caused by lower temperature and by pressure.[11]

The temperature component is caused by water drawing heat away from the body and causing vasoconstriction of the cutaneous blood vessels within the body to conserve heat.[12][13][14] The body detects an increase in the blood pressure and inhibits the release of vasopressin (also known as antidiuretic hormone (ADH)), causing an increase in the production of urine. The pressure component is caused by the hydrostatic pressure of the water directly increasing blood pressure. Its significance is indicated by the fact that the temperature of the water does not substantially affect the rate of diuresis.[15] Partial immersion of only the limbs does not cause increased urination. Thus, the hand in warm water trick (immersing the hand of a sleeping person in water to make them urinate) has no support from the mechanism of immersion diuresis. On the other hand, sitting up to the neck in a pool for a few hours clearly increases the excretion of water, salts, and urea.[15]

Cold-induced diuresis

[edit]

Cold-induced diuresis, or cold diuresis, is a phenomenon that occurs in humans after exposure to a hypothermic environment, usually during mild to moderate hypothermia.[16] It is currently thought to be caused by the redirection of blood from the extremities to the core due to peripheral vasoconstriction, which increases the fluid volume in the core. Overall, acute exposure to cold is thought to induce a diuretic response due to an increase mean arterial pressure.[17]

The arterial cells of the kidneys sense the increase in blood pressure and signal the kidneys to excrete superfluous fluid in an attempt to stabilize the pressure. The kidneys increase urine production and fill the bladder; when the bladder fills, the individual may then feel the urge to urinate. This phenomenon usually occurs after mental function has decreased to a level significantly below normal. Cold diuresis has been observed in cases of accidental hypothermia as well as a side effect of therapeutic hypothermia, specifically during the induction phase.[18][19]

See also

[edit]

References

[edit]

Further reading

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Diuresis

View on Grokipedia
from Grokipedia
Diuresis is the physiological or pathological process by which the kidneys produce and excrete an increased volume of , typically exceeding 3 liters per day in adults, beyond the normal range of 0.8 to 2 liters. This condition arises when the kidneys filter excess fluid or solutes from the blood, leading to more and potential disruptions in fluid and balance. Diuresis can be categorized into several types based on its underlying mechanisms and triggers. Osmotic diuresis occurs when high concentrations of poorly reabsorbable solutes, such as glucose in uncontrolled diabetes mellitus or in medical treatments, draw additional water into the renal tubules, inhibiting water reabsorption and increasing urine output. Water diuresis, in contrast, involves the production of large volumes of dilute urine due to impaired renal concentrating ability, as seen in caused by deficiencies in antidiuretic hormone or renal response to it. Pressure diuresis is a regulatory mechanism where elevated renal pressure enhances sodium and water excretion to help maintain and arterial pressure . Additionally, forced diuresis is often pharmacologically induced using agents to promote fluid removal in conditions like , , or . The causes of diuresis span physiological responses, medical conditions, and external factors. Common pathological triggers include from , hypercalcemia, or kidney disorders, while iatrogenic causes involve medications such as (e.g., ) or osmotic agents. Lifestyle and environmental influences, like excessive or alcohol intake, high-altitude exposure, or cold temperatures, can also provoke transient diuresis by stimulating renal fluid excretion. Clinically, while therapeutic diuresis aids in managing fluid overload and cardiovascular diseases, uncontrolled diuresis may result in , disturbances such as or , fatigue, and , necessitating prompt evaluation and treatment of the root cause.

Introduction

Definition

Diuresis refers to the increased or excessive production of by the kidneys, typically defined as a daily output exceeding 3 liters in adults. This physiological process involves enhanced and of fluid through the renal system, often in response to various stimuli that alter . In contrast to normal production, which ranges from 800 milliliters to 2 liters per day in healthy adults under baseline conditions, diuresis represents a deviation toward higher volumes. It must be distinguished from , which is the clinical symptom of excessive (often >3 liters per day), while diuresis specifically denotes the underlying renal mechanism driving this output; , conversely, indicates reduced production (<500 milliliters per day). The kidneys play a central role in maintaining overall , with diuresis serving as a key regulatory response. The term "diuresis" originates from the Greek word diourein, meaning "to urinate," combining dia- (through) and ourein (to urinate). It entered medical literature in the late 17th century, with the first known English usage recorded around 1681, reflecting early observations of urinary phenomena in clinical contexts.

Clinical Significance

Diuresis plays a central role in the therapeutic management of fluid overload associated with conditions such as heart failure, hypertension, and edema. In heart failure, loop diuretics promote diuresis to alleviate congestion and improve cardiac function, serving as a cornerstone of treatment to reduce symptoms like dyspnea and peripheral swelling. Similarly, thiazide and loop diuretics are employed to lower blood pressure in hypertension by enhancing sodium and water excretion, thereby decreasing intravascular volume. For edema, whether due to liver cirrhosis, nephrotic syndrome, or other causes, diuretics facilitate fluid removal to prevent complications like pulmonary edema or skin breakdown. Clinically, diuresis serves as a key diagnostic indicator for underlying disorders, particularly when excessive urine output signals disruptions in . In , exceeding 3 liters per day with dilute urine (osmolality <300 mOsm/kg) prompts evaluation through water deprivation tests to confirm impaired antidiuretic hormone action or renal response. In the context of renal disorders, a polyuric phase following the oliguric stage of (AKI) often indicates recovery of tubular function, with urine output increasing markedly as glomerular resumes. This pattern helps differentiate resolving AKI from persistent renal failure or other causes of , such as solute diuresis in . While beneficial, excessive diuresis carries significant risks, including electrolyte imbalances, , and potential exacerbation of kidney injury. Diuretic-induced arises from increased potassium excretion in the distal tubule, which can lead to arrhythmias or if not monitored. Overly aggressive diuresis may cause volume depletion and , resulting in prerenal or . In vulnerable patients, such as those with preexisting renal impairment, rapid fluid shifts can precipitate or worsen AKI through hypoperfusion. Recent clinical guidelines underscore the importance of vigilant monitoring of diuresis in intensive care settings to guide interventions and assess outcomes. The : Improving Global Outcomes (KDIGO) framework emphasizes hourly urine output tracking in AKI patients, with increased output signaling potential recovery and warranting adjustments in fluid management to avoid complications. This approach, updated in ongoing KDIGO efforts as of 2023, prioritizes individualized monitoring to balance diuresis benefits against risks in critically ill individuals.

Physiology of Urine Production

Normal Mechanisms

Urine production by the , a process central to maintaining fluid and balance in the body and that underlies diuresis when increased, occurs through the , the functional unit of the , consisting of approximately one million units per , each comprising a (including the and ) and a renal tubule that includes the proximal convoluted tubule (PCT), (with descending and ascending limbs), (DCT), and connecting tubule leading to the collecting duct. formation begins with , where is filtered across the glomerular wall into Bowman's space, driven primarily by hydrostatic (approximately 55 mmHg). The filtration barrier, composed of fenestrated , glomerular basement membrane, and foot processes, selectively permits passage of water, ions, , , and small molecules while retaining larger proteins and blood cells. The (GFR), the volume of fluid filtered per unit time, averages 120–125 mL/min in healthy adults, equivalent to about 180 liters per day, and is regulated by autoregulatory mechanisms to maintain stability despite changes in . Following filtration, the resulting ultrafiltrate undergoes extensive and along the renal tubule to reclaim essential substances and concentrate wastes into . In the PCT, which is highly permeable to and solutes, approximately 65% of the filtered sodium (Na⁺), , chloride (Cl⁻), bicarbonate (HCO₃⁻), glucose, and are reabsorbed via (e.g., Na⁺/K⁺-ATPase on the basolateral membrane) coupled with paracellular and transcellular pathways, ensuring isosomotic reabsorption to maintain tubular fluid osmolarity. The establishes the medullary osmotic gradient crucial for urine concentration: the descending limb, permeable to via aquaporin-1 (AQP1) channels, allows passive reabsorption as the tubular fluid becomes hypertonic (up to 1200 mOsm/L); the ascending limb, impermeable to , actively reabsorbs Na⁺, Cl⁻, potassium (K⁺), calcium (Ca²⁺), and magnesium (Mg²⁺) via the Na⁺-K⁺-2Cl⁻ cotransporter (NKCC2), diluting the fluid to about 100 mOsm/L. In the DCT and connecting tubule, fine-tuning occurs with reabsorption of 5–10% of filtered Na⁺ and Cl⁻ via Na⁺-Cl⁻ (NCC), along with Ca²⁺ regulated by , and minimal movement due to low permeability unless influenced by regulatory factors. Under normal conditions, about 99% of the glomerular filtrate is reabsorbed, primarily in the PCT and , resulting in a final volume of 1–2 liters per day. Water and solute handling culminates in the collecting ducts, where principal cells facilitate facultative water reabsorption through (AQP2) water channels inserted into the apical membrane, allowing osmotic equilibration with the hypertonic medullary interstitium to concentrate up to four times plasma osmolarity. This process is responsive to systemic signals like antidiuretic for precise control, as detailed in regulatory sections. The approximate daily volume can be estimated by the equation: Daily urine volume≈GFR×(1−fractional reabsorption)\text{Daily urine volume} \approx \text{GFR} \times (1 - \text{fractional reabsorption}) where GFR is ~180 L/day and fractional reabsorption is ~0.99, yielding ~1.8 L/day.

Regulatory Hormones and Factors

Diuresis is tightly regulated by a suite of hormones and neural mechanisms that respond to changes in plasma osmolality, blood volume, and electrolyte balance to maintain fluid homeostasis. Among these, antidiuretic hormone (ADH), also known as vasopressin, plays a central role in modulating water excretion. Synthesized in the hypothalamus and released from the posterior pituitary gland, ADH is secreted primarily in response to elevated plasma osmolality or reduced blood volume. It acts on V2 receptors in the principal cells of the kidney's collecting ducts, inducing the insertion of aquaporin-2 water channels into the apical membrane, which enhances water reabsorption and thereby reduces urine volume and promotes antidiuresis. This mechanism ensures that free water is conserved during states of dehydration or hyperosmolality, preventing excessive fluid loss. Aldosterone, a mineralocorticoid hormone produced by the zona glomerulosa of the adrenal cortex, further contributes to fluid balance by influencing sodium handling in the nephron. It binds to mineralocorticoid receptors in the late distal convoluted tubule and collecting ducts, upregulating the expression and activity of epithelial sodium channels (ENaC) and Na+/K+-ATPase pumps on the basolateral membrane. This promotes sodium reabsorption from the tubular lumen into the bloodstream, creating an osmotic gradient that indirectly drives water retention and diminishes diuresis. Aldosterone secretion is stimulated by hyperkalemia, angiotensin II, or low sodium delivery to the distal nephron, ensuring volume conservation in hypovolemic conditions. In contrast, (ANP), released from atrial cardiomyocytes in response to atrial stretch during expansion, counteracts these antidiuretic effects to promote and diuresis. ANP inhibits sodium in the collecting ducts by suppressing aldosterone synthesis and antagonizing its actions, while also increasing through afferent arteriolar and efferent arteriolar . Additionally, it reduces renin release and sympathetic outflow, further facilitating solute and water to normalize expanded extracellular volume. This thus serves as a key natriuretic factor in volume-overload states. Neural regulation, particularly via the , integrates these hormonal signals by modulating renal . Efferent sympathetic nerves innervate the renal vasculature and tubules, releasing norepinephrine that binds to alpha-1 adrenergic receptors, inducing of afferent and . This reduces renal blood flow and , while stimulating renin release from juxtaglomerular cells, thereby enhancing responses during stress or . Sympathetic activation also directly promotes sodium reabsorption in the , contributing to overall fluid retention and suppression of diuresis. These elements are coordinated through feedback loops, notably the renin-angiotensin-aldosterone system (RAAS), which is activated in low-volume states to curtail diuresis. Low renal perfusion triggers juxtaglomerular cells to secrete renin, which cleaves angiotensinogen to angiotensin I, subsequently converted to angiotensin II by . Angiotensin II stimulates aldosterone release, , and , while also enhancing sodium reabsorption across the . This cascade restores blood volume by promoting retention of sodium and water, effectively reducing urinary output until is achieved.

Types of Diuresis

Osmotic Diuresis

Osmotic diuresis arises from the presence of non-reabsorbable solutes in the renal tubular lumen, which generate an osmotic gradient that impairs along the . These solutes, such as glucose or , remain in the tubular fluid and osmotically retain , reducing the kidney's ability to concentrate urine and thereby increasing urine volume independent of hormonal regulation. This process primarily affects the and descending limb of the , where the osmotic effect limits the of and associated solutes like sodium. Common causes include uncontrolled diabetes mellitus, where hyperglycemia leads to glucosuria exceeding the tubular maximum reabsorption capacity for glucose (approximately 300-375 mg/min), resulting in osmotic pull of water into the urine. Elevated urea levels from high-protein diets or tissue catabolism can also induce this effect by increasing the solute load in the tubules. Additionally, therapeutic administration of osmotic agents like , often used in conditions such as , directly contributes by being filtered but not reabsorbed, thereby driving fluid excretion. Clinically, osmotic diuresis is characterized by polyuria with urine osmolality typically exceeding 300 mOsm/kg, reflecting the solute-driven nature rather than dilute urine seen in water diuresis. The daily solute excretion often surpasses 900-1,000 mOsm/day, far above the normal range of 600-900 mOsm/day, confirming the osmotic load as the primary driver. The osmotic diuresis rate can be approximated using the equation for urine volume: V≈urine solute excretionmaximum tubular reabsorption capacityV \approx \frac{\text{urine solute excretion}}{\text{maximum tubular reabsorption capacity}} where maximum tubular reabsorption capacity relates to the nephron's ability to handle solute without excessive water loss, often modeled through limits (e.g., around 300 mOsm/kg in moderate diuresis). For instance, with a solute of 1,000 mOsm/day and effective tubular osmolality of 300 mOsm/L, urine volume approximates 3.3 L/day. Consequences of osmotic diuresis include significant due to excessive free water loss, which can exacerbate or . Electrolyte imbalances, particularly , arise from increased distal tubular flow stimulating potassium secretion and secondary from volume depletion. In severe cases, profound may precipitate by reducing renal and .

Rebound Diuresis

Rebound diuresis refers to the abrupt increase in urine production that occurs during the recovery phase of (AKI), particularly following (ATN) or obstructive uropathy. This phenomenon is part of the polyuric stage in AKI resolution, where kidney function begins to normalize after a period of or . It typically manifests as a transient lasting 10–14 days, distinguishing it from sustained diuresis in other conditions. The mechanism involves the recovery of tubular epithelial cells through processes such as proliferation, migration, and dedifferentiation, which restore (GFR) ahead of full tubular capacity. During recovery, damage to the proximal tubules and thick ascending limb impairs sodium and , leading to osmotic and solute diuresis as accumulated solutes are excreted; similarly, in obstructive uropathy, relief of backpressure normalizes while tubular function lags, causing rapid normalization of . This lag results from disrupted , reduced Na⁺-K⁺-ATPase activity, and impaired function, perpetuating high urine volume until is reestablished. Common triggers include rehydration after volume depletion in prerenal AKI, discontinuation of nephrotoxic agents causing toxic , or surgical relief of urinary obstruction in obstructive uropathy. Characteristics feature a surge in urine output exceeding 200 mL per hour for at least two consecutive hours or more than 3 L per day, often emerging within 24–48 hours of the inciting resolution and accompanied by electrolyte losses such as sodium and . Monitoring requires vigilant assessment of fluid balance and to guide replacement therapy, as unchecked can lead to , , and further renal stress; intravenous fluids matching 50–75% of urine output are typically administered initially, with adjustments based on hemodynamic stability. This phase signals renal recovery in AKI but demands careful management to prevent complications. The polyuric recovery phase, akin to rebound diuresis, was first systematically observed in post-operative patients experiencing AKI in the mid-20th century, highlighting its association with surgical insults and fluid shifts.

Pharmacologically Induced Diuresis

Forced Diuresis

Forced diuresis refers to a historical therapeutic intervention involving the administration of intravenous fluids and sometimes diuretics to increase production and accelerate the renal elimination of certain in cases of or . In contemporary practice (as of 2025), forced diuresis is rarely used and considered largely obsolete for most overdoses, having been supplanted by more effective methods such as multiple-dose activated charcoal, supportive care, and extracorporeal removal (e.g., ) for severe cases. When applied historically, the procedure entailed infusing isotonic fluids, such as normal saline or dextrose solutions, at rates exceeding maintenance levels, sometimes combined with like , to achieve high output. However, current guidelines emphasize avoiding excessive diuresis due to risks and inefficacy in maintaining optimal conditions for toxin elimination. Historically, forced diuresis was applied in the management of acute overdoses involving renally excreted drugs, such as salicylates (e.g., aspirin) and barbiturates (e.g., ), to increase clearance and shorten the duration of toxicity. For , moderate to severe cases with intact renal function were treated with urine alkalinization as an adjunct to supportive care, often while preparing for if needed; forced diuresis itself is not recommended, as high urine flow hinders pH control. In barbiturate intoxication, 1960s-era use demonstrated reduced morbidity and mortality by enhancing , though it has been supplanted by multiple-dose activated charcoal and other interventions in modern practice. The technique was most beneficial for water-soluble toxins with pKa values allowing in urine, but its efficacy was limited for substances primarily metabolized by the liver or eliminated via non-renal routes, such as those dependent on biliary . Key historical techniques included manipulation of urine pH to optimize : alkalinization using (e.g., 1-2 mEq/kg bolus followed by infusion of 100-150 mEq in 1 L D5W at 1.5-2 times maintenance rate) to achieve a urine pH of 7.5-8.0 for acidic drugs like salicylates, which increases and reduces tubular . Current protocols for alkalinization target urine output of 2-3 mL/kg/hour (approximately 100-200 mL/hour in adults) via adequate hydration without diuretics. For basic drugs such as amphetamines or , urine acidification with agents like was proposed to enhance excretion by promoting in acidic conditions (urine pH <5.5), though this approach is infrequently used due to risks of systemic and is not routinely recommended. Potential risks include fluid overload, which can precipitate or exacerbate , particularly in patients with compromised cardiac or renal function. Electrolyte disturbances, such as , , or from therapy, require vigilant correction with supplementation and monitoring. Additionally, the intervention may fail to significantly impact overall clearance if renal function is impaired or if the toxin has low renal elimination, potentially delaying more definitive treatments like extracorporeal removal. These risks underscore the need for careful patient selection and intensive care setting application, though its limited modern use mitigates these concerns. This historical approach is contextualized by guidelines, including the American College of Medical Toxicology's (ACMT) recommendations for , which endorse urine alkalinization (without forced diuresis) to enhance excretion by over 10-fold when urine pH reaches 7.5-8.0, particularly in cases not immediately requiring . The ACMT's joint with the European Association of Poisons Centres and Clinical Toxicologists further validates urine alkalinization for select poisons like salicylates and certain phenoxy herbicides, based on clinical evidence reducing and improving outcomes, though it emphasizes that such measures alone are insufficient for life-threatening intoxications.

Classes of Diuretics

Diuretics are classified primarily based on their site of action within the and their specific mechanisms for inhibiting sodium , which ultimately promotes and induces diuresis. This classification includes , diuretics, potassium-sparing diuretics, osmotic diuretics, and inhibitors, each targeting distinct segments of the renal tubule to varying degrees of natriuretic potency. Loop diuretics, such as , act on the thick ascending limb of the by inhibiting the Na-K-2Cl cotransporter, preventing of sodium, potassium, and chloride ions. This inhibition disrupts the countercurrent multiplier system, leading to potent diuresis with up to 20–25% of filtered sodium excreted. Thiazide diuretics, exemplified by hydrochlorothiazide, target the distal convoluted tubule where they block the Na-Cl cotransporter, reducing sodium and chloride . Their effect is milder compared to , typically resulting in 5–10% of filtered sodium excretion, and they are often used for management alongside their diuretic properties. Potassium-sparing diuretics, including , function in the late distal tubule and collecting duct by antagonizing aldosterone at the , thereby inhibiting sodium reabsorption via epithelial sodium channels while minimizing loss. These agents produce weak diuresis, excreting only about 1–2% of filtered sodium, but are valuable for preventing when combined with other diuretics. Osmotic diuretics, such as mannitol, are freely filtered but not reabsorbed, creating an osmotic gradient in the proximal tubule that limits water and sodium reabsorption downstream. They primarily induce water diuresis rather than strong natriuresis and are commonly employed in settings requiring rapid volume expansion prevention, like cerebral edema. Carbonic anhydrase inhibitors, like acetazolamide, operate in the proximal tubule by blocking the enzyme carbonic anhydrase, which impairs bicarbonate reabsorption and secondarily reduces sodium and water uptake via the Na-H exchanger. This results in mild diuresis, often limited by the development of metabolic acidosis, making them suitable for altitude sickness or glaucoma rather than primary volume overload. The efficacy of diuretics is commonly assessed using the (FENa), calculated as: FENa=(urine Na/plasma Naurine Cr/plasma Cr)×100\text{FENa} = \left( \frac{\text{urine Na} / \text{plasma Na}}{\text{urine Cr} / \text{plasma Cr}} \right) \times 100 This metric quantifies the percentage of filtered sodium excreted, providing insight into diuretic responsiveness and renal handling of sodium.

Environmentally Induced Diuresis

Immersion Diuresis

Immersion diuresis refers to the increased urine production induced by water immersion, primarily through hydrostatic gradients that alter cardiovascular dynamics. During immersion, the external hydrostatic compresses lower body veins, redistributing approximately 700 ml of blood toward the central circulation and expanding central . This expansion stretches the atrial walls, stimulating the release of (ANP), which promotes and diuresis by inhibiting sodium reabsorption in the kidneys. Concurrently, the volume shift suppresses antidiuretic hormone (ADH, or ) secretion and the renin-angiotensin-aldosterone system (RAAS), reducing water reabsorption and aldosterone-mediated sodium retention. The primary triggers for immersion diuresis are full or partial body immersion in water, typically head-out immersion to the neck in thermoneutral water (32–36°C) to isolate effects from influences. Effects begin within minutes of immersion, with left atrial increasing from approximately 26 mm to 32 mm, initiating hormonal responses. Physiological effects include a rapid rise in urine output, often peaking at 7.2 ml/min in the second hour of immersion, representing a doubling or more compared to baseline levels of 0.5–1 ml/min. increases markedly from near zero to 4.4 ml/min initially, driven by ADH suppression from 0.76 pg/ml to 0.23 pg/ml. Sodium excretion rises up to ninefold, reaching 228 μmol/min, while excretion also enhances due to reduced tubular , contributing to overall fluid loss. increases by 25–33%, and plasma volume may decline by 14–20% over 6–8 hours as diuresis progresses. This phenomenon has been extensively studied in and microgravity research as an analog for , where similar fluid shifts occur without gravity. has utilized water immersion protocols to simulate conditions, observing urine output increases of 3–10 times baseline and aiding in countermeasures for and renal function adaptations during missions. Immersion diuresis is transient, resolving shortly after exiting the water as hydrostatic pressure normalizes and hormonal balances restore; no long-term health impacts have been documented in healthy individuals.

Cold-Induced Diuresis

Cold-induced diuresis occurs primarily through cardiovascular adaptations to cold stress, where peripheral redirects blood flow from the extremities to the core, thereby increasing central . This central stretches the atrial walls, promoting the release of (ANP), which enhances renal excretion of sodium and water, while simultaneously suppressing antidiuretic hormone (ADH) secretion to facilitate . The net result is an inhibition of water reabsorption in the renal collecting ducts, leading to increased urine production. This phenomenon is triggered by exposure to cold environments or induced hypothermia, typically when ambient temperatures fall below 10°C or core body temperature drops toward hypothermic levels (below 35°C), as seen in outdoor activities, , or therapeutic cooling protocols for conditions like post-cardiac care. Common in scenarios involving prolonged exposure without adequate insulation, it serves as a thermoregulatory response but can exacerbate fluid loss if unchecked. Characteristics of cold-induced diuresis include a notable rise in urine output, often by approximately 50 mL per hour during therapeutic induction, accompanied by decreased indicative of dilute urine due to enhanced . This response is particularly evident as a side effect in induced for management, where it contributes to potential imbalances alongside the primary diuresis. Clinically, cold-induced diuresis poses a risk of and in hypothermic patients, compounded by reduced sensation and potential delays in . Management involves close monitoring of , urine output, and , with aggressive administration of warmed intravenous s to counteract losses, as recommended in protocols for accidental and therapeutic . Research on cold-induced diuresis has highlighted its mechanisms and implications, with a seminal 2013 study characterizing urine output changes during post-cardiac arrest therapeutic , noting consistent cold diuresis without significant rewarming anti-diuresis. Subsequent investigations up to 2020 have reinforced the roles of ANP and ADH without major paradigm shifts, emphasizing its persistence as a key consideration in cold stress physiology.

High-Altitude Diuresis

High-altitude diuresis is the increased urine production triggered by hypobaric hypoxia upon ascent to elevations typically above 2,500 meters, serving as a key acclimatization mechanism to improve oxygenation. The primary mechanism involves hypoxia-induced suppression of antidiuretic hormone (ADH) release from the posterior pituitary, alongside activation of the renin-angiotensin-aldosterone system initially but eventual natriuresis due to atrial natriuretic peptide (ANP) and reduced renal tubular reabsorption of sodium and water. Increased ventilation from hypoxic ventilatory response also contributes to respiratory alkalosis, further inhibiting ADH and promoting dilute urine excretion. Triggers include rapid ascent to high altitudes without , such as in , , or travel to regions like the or , where of oxygen drops significantly. Effects onset within hours of exposure, with diuresis peaking in the first 1-2 days before stabilizing. Characteristics include a 20-50% increase in urine output compared to sea-level baseline, often reaching 2-3 liters per day initially, with reduced (around 200-400 mOsm/kg) reflecting impaired concentrating ability. This fluid loss, combined with insensible losses from , can lead to a 1-2 liter negative in the first 24 hours, aiding hemoconcentration and improved oxygen delivery but risking if fluid intake is inadequate. Clinically, high-altitude diuresis facilitates by reducing plasma volume and increasing concentration, lowering the risk of acute mountain sickness (AMS). However, in unacclimatized individuals, it may contribute to , , and if not managed with adequate hydration. Prophylactic enhances this diuretic response to accelerate acclimatization. No long-term renal impacts are noted in healthy individuals with proper management.

References

  1. https://www.healthline.com/health/diuresis
  2. https://www.webmd.com/diabetes/what-is-diuresis
  3. https://medlineplus.gov/ency/article/001266.htm
  4. https://www.webmd.com/diabetes/what-is-diabetes-insipidus
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC3536597/
  6. https://www.ncbi.nlm.nih.gov/books/NBK557838/
  7. https://my.clevelandclinic.org/health/treatments/21826-diuretics
  8. https://www.ncbi.nlm.nih.gov/books/NBK459387/
  9. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/diuresis
  10. https://www.ncbi.nlm.nih.gov/books/NBK606132/
  11. https://pubmed.ncbi.nlm.nih.gov/26687922/
  12. https://www.ncbi.nlm.nih.gov/books/NBK607447/
  13. https://www.etymonline.com/word/diuresis
  14. https://www.merriam-webster.com/dictionary/diuresis
  15. https://www.jacc.org/doi/10.1016/j.jacc.2019.12.059
  16. https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/diuretics/art-20048129
  17. https://www.ncbi.nlm.nih.gov/books/NBK537591/
  18. https://empendium.com/mcmtextbook/chapter/B31.II.14.1.
  19. https://www.ajkd.org/article/s0272-6386%2815%2901342-6/fulltext
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC7347069/
  21. https://www.ncbi.nlm.nih.gov/books/NBK441896/
  22. https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf
  23. https://annalsofintensivecare.springeropen.com/articles/10.1186/s13613-024-01342-x
  24. https://www.ncbi.nlm.nih.gov/books/NBK538339/
  25. https://www.niddk.nih.gov/health-information/kidney-disease/kidneys-how-they-work
  26. https://www.ncbi.nlm.nih.gov/books/NBK500032/
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC3760239/
  28. https://www.ncbi.nlm.nih.gov/books/NBK554411/
  29. https://www.ncbi.nlm.nih.gov/books/NBK279384/
  30. https://pmc.ncbi.nlm.nih.gov/articles/PMC5243240/
  31. https://www.ncbi.nlm.nih.gov/books/NBK526069/
  32. https://pubmed.ncbi.nlm.nih.gov/30252325/
  33. https://www.ncbi.nlm.nih.gov/books/NBK470339/
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC9338908/
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC8950497/
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC4163710/
  37. https://pubmed.ncbi.nlm.nih.gov/23737201/
  38. https://www.ncbi.nlm.nih.gov/books/NBK470410/
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC7152415/
  40. https://www.sciencedirect.com/topics/medicine-and-dentistry/osmotic-diuresis
  41. https://www.ncbi.nlm.nih.gov/books/NBK470458/
  42. https://www.ajkd.org/article/S0272-6386%2815%2901342-6/fulltext
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC8116912/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC4896141/
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC3919808/
  46. https://www.ncbi.nlm.nih.gov/books/NBK499875/
  47. https://emedicine.medscape.com/article/1009987-treatment
  48. https://www.rch.org.au/clinicalguide/guideline_index/Salicylates_Posioning/
  49. https://www.ncbi.nlm.nih.gov/books/NBK470276/
  50. https://www.acmt.net/wp-content/uploads/2022/06/PRS_130313_Management-Priorities-in-Salicylate-Toxicity.pdf
  51. https://www.clintox.org/wp-content/uploads/2016/04/Position-Paper-on-Urine-Alkalinization.pdf
  52. https://pmc.ncbi.nlm.nih.gov/articles/PMC9072265/
  53. https://pmc.ncbi.nlm.nih.gov/articles/PMC5933583/
  54. https://journals.sagepub.com/doi/10.1258/acb.2011.011281
  55. https://www.mdcalc.com/calc/60/fractional-excretion-sodium-fena
  56. https://giornaleitalianodinefrologia.it/2018/01/water-immersion-model-nephrology-from-hydrotherapy-to-weightlessness/
  57. https://pmc.ncbi.nlm.nih.gov/articles/PMC2231110/
  58. https://ntrs.nasa.gov/api/citations/19760011693/downloads/19760011693.pdf
  59. https://pubmed.ncbi.nlm.nih.gov/15354034/
  60. https://pubmed.ncbi.nlm.nih.gov/9597114/
  61. https://journals.physiology.org/doi/10.1152/ajprenal.00430.2005
  62. https://nap.nationalacademies.org/read/5197/chapter/14
  63. https://www.aafp.org/pubs/afp/issues/2004/1215/p2325.html
  64. https://pubmed.ncbi.nlm.nih.gov/24380030/
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC9630589/
  66. https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2020.00756/full
  67. https://www.ncbi.nlm.nih.gov/books/NBK232881/
  68. https://www.cdc.gov/yellow-book/hcp/environmental-hazards-risks/high-altitude-travel-and-altitude-illness.html
Add your contribution
Related Hubs
User Avatar
No comments yet.